Results

Total Results: 2,259 records

Showing results for "measurement".

2121. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias-individual-studies_methods.pdf
      March 01, 2012 - in full protocol and published materials No Yes Outcome measures Yes (potential for outcome measurement … and timings, diagnostic thresholds, recall from memory, inadequate assessor blinding, and faulty measurement … medical records for control arm versus questionnaires for intervention arm) constitute a source of measurement … AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic … attrition; adequate description of the sample; steps to minimize bias (i.e., randomization, allocation, measurement

2122. Evidence Report on the (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
      May 19, 2010 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: May 19, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update I. Background and Objectives for the Sys…

2123. Pharmacologic and Nonpharmacologic Treatments of Post-Traumatic Stress Disorder (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-protocol.pdf
      July 10, 2018 - others); number who completed treatment; percent of total sessions attended; number who completed measurement … Number of participants who completed measurement for primary PTSD outcome measure at each time point

2124. Pharmacologic and Nonpharmacologic Treatments of Post-Traumatic Stress Disorder (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol.pdf
      July 10, 2018 - others); number who completed treatment; percent of total sessions attended; number who completed measurement … Number of participants who completed measurement for primary PTSD outcome measure at each time point

2125. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
      August 22, 2008 - Observational studies will be assessed for sample size, participant selection method, exposure measurement … ; clear description of the population, setting, interventions, and comparison groups; appropriate measurement

2126. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
      May 07, 2010 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: May 07, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs) …

2127. Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension – An Update of the 2007 Report | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update/research-protocol
      May 07, 2010 - Current Page Topic Timeline Mar. 16, 2010 Topic Initiated May. 7, 2010 Research Protocol Jun. 13, 2011 Systematic Review Oct. 7, 2011 Disposition of Comments Report Mar. 28, 2016 Surveillance Report Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARB…

2128. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
      September 02, 2016 - clinical outcomes, adverse events): measure of n-3 intake/exposure must have occurred ≥1 year prior to measurement … done within a prospective study): measure of n-3 intake/exposure must have occurred ≥1 year prior to measurement … one of the following: ** Instrument reported but no adequate description regarding n-3 FA intake measurement

2129. - (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_appendixes.pdf
      January 01, 2009 - Measurement is usually done with dual energy x-ray absorptiometry (DEXA). … For example, a value with 95% confidence interval implies that when a measurement is made 100 times … Leucine Oxidation (LeuOX): Measurement made with leucine isotope that represents protein oxidation, … D-5 Rate of Appearance of Leucine (LeuRa): Measurement made with leucine isotope that represents … Measurement of quality of well being in a child and adolescent cystic fibrosis population.

2130. DST_Draft_Protocol_Nov_4_2013_clean (2) (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
      November 12, 2013 - a clear description of the population, setting, interventions, and comparison groups; appropriate measurement

2131. Decision Support Tools for Screening and Treatment Decisions in Early Cancer | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/cancer-decision-support-tools/research-protocol
      November 12, 2013 - , a clear description of the population, setting, interventions, and comparison groups; appropriate measurement

2132. Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research
      September 25, 2013 - Current Page Topic Timeline Aug. 4, 2010 Topic Suggestion Nov. 22, 2011 Research Protocol Sep. 25, 2013 Systematic Review Feb. 13, 2014 Disposition of Comments Report Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment Systematic Review Archived September 25, 2013 Web Version [NL…

2133. Ch 1-User-Guide-To-Ocer 130129 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
      August 13, 2012 - quality of life as an outcome, but do not believe there is an adequate measure of quality of life, then measurement

2134. Treatments for Ankyloglossia and Ankyloglossia with Concomitant Lip-tie | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/ankyloglossia/research
      May 04, 2015 - Current Page Topic Timeline Mar. 14, 2013 Topic Suggestion Jun. 30, 2014 Research Protocol May. 4, 2015 Systematic Review Aug. 26, 2015 Disposition of Comments Report Treatments for Ankyloglossia and Ankyloglossia with Concomitant Lip-tie Systematic Review Archived May 4, 2015 Web Version [NLM Site] Download Main …

2135. Knowledge Briefs: Public Deliberation | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/deliberative-methods/research
      February 01, 2013 - Knowledge Briefs: Public Deliberation Research Report February 1, 2013 Download Main Document PDF 139.1 KB Related Files Download Knowledge Brief #2: Methods [PDF · 137.4 KB] These reports ( Knowledge Brief No. 1 ; Knowledge Brief No. 2 ) are available in PDF (178 kB) only. People using assistive tec…

2136. Interventions for Preventing Cognitive Decline, Mild Cognitive Impairment, and Alzheimer’s Disease | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/cognitive-decline/research-protocol
      March 23, 2016 - assess the effects by the duration of followup, especially the lag between the end of treatment and the measurement

2137. Peripheral-Artery-Disease-Treatment Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
      May 01, 2013 - For observational studies, additional elements such as methods for selection of participants, measurement … We observed similar results in studies that were excluded due to measurement of peak walking time rather … Similar results were observed in studies excluded due to measurement of claudication onset time rather

2138. Early Imaging for Back Pain and Clinical Outcomes in Older Adults: A Brief Summary of Findings and Key Points for Clinician-Patient Discussions | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/back-pain-imaging/clinician
      May 13, 2016 - Early Imaging for Back Pain and Clinical Outcomes in Older Adults: A Brief Summary of Findings and Key Points for Clinician-Patient Discussions Clinician Summary May 13, 2016 Download Main Document PDF 176.7 KB Description of This Summary This is a summary of an original research article that was pu…

2139. Back-Pain-Imaging Clinician (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-imaging_clinician.pdf
      April 01, 2016 - Early Imaging for Back Pain and Clinical Outcomes in Older Adults: A Brief Summary of Findings and Key Points for Clinician-Patient Discussions KEY CLINICAL ISSUE What were the clinical outcomes and use of health care resources among older adults who received early imaging when compared with those who did not re…

2140. Disposition of Comments Report for Prevention of Healthcare-Associated Infections (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_disposition-comments.pdf
      November 30, 2012 - body of literature is that the heterogeneity is not limited to site differences, but also includes measurement